₹4,890.00
₹-42.00 (-0.85%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹1,85,924 Cr
P/E
86.24
ROE
25.49%
ROCE
13.85%
About Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals is engaged in manufacturing, developing and marketing of generic pharmaceutical formulations.
Founded
1972
CEO
Sudhir Mehta
Employees
20,341
HQ
Ahmedabad, Gujarat
About Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals is engaged in manufacturing, developing and marketing of generic pharmaceutical formulations.
Founded:1972
CEO:Sudhir Mehta
Employees:20,341
HQ:Ahmedabad, Gujarat
Finished Products
1Sales
₹41,352.10Cr2Production linked incentive in
₹347.17Cr3Export Benefits
₹194.10Cr4Other Operating Income
₹161.11Cr5Compensation&Settlement Income
₹43.27Cr6Income from Product Regst Doss
₹17.74Cr7Government Grant Income
₹5.88CrRaw Materials
1Raw Materials Consumed
₹5,607.79Cr2Trading Purchases
₹1,280.81Cr3Purchases of Traded Goods
₹1,164.44Cr4Packing Materials
₹657.67CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹5,250
52W Low
₹3,481
Volume277.58K
Avg VolumeN/A
Beta0.25
Dividend Yield0.69%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
86.24x
Valuation
P/B Ratio
22.11x
Valuation
EPS
₹56.68
Valuation
Dividend Yield
0.69%
Valuation
ROE
25.49%
Profitability
ROCE
13.85%
Profitability
Revenue by Segment
Contribution & growth by business line
Generic Formulation BusinessRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
58.4%
International
41.6%
India58.4%
Other countries13.2%
USA9.7%
Brazil9.7%
Germany & Malta8.9%
Strategic Relations
Collaborations, joint ventures & subsidiaries
S
Sanofi
France
0.00% stakeN
Novo Nordisk
Denmark
0.00% stakeW
William Harvey Research Institute
United Kingdom
0.00% stakeForensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
1.79x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
21.6%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.